To continue to elucidate the factors and pathways that participate in AR signaling in prostate cancer, we performed a genome wide RNAi screen to identify new AR regulators that contribute to AR activity and potentially CRPC [8]. The gene discussed is AR; the disease is prostate carcinoma.